Trial Profile
Effects of ONO-2506PO in patients with Alzheimer's disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Jun 2012
Price :
$35
*
At a glance
- Drugs Arundic acid (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 13 Nov 2007 Status change from in progress to completed.
- 22 Oct 2005 New trial record.